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Loeffler’s endocarditis and cardiac manifestations of the hypereosinophilic syndrome (HES) are rare and difficult to
diagnose. We report a case of in a 36 year-old female with a history of rheumatoid arthritis with disabling dyspnea. The
transthoracic echocardiogram demonstrated normal systolic cardiac functions and a left ventricular apical thrombus.
However, using cardiovascular magnetic resonance (CMR) with inversion-recovery (IR) delayed enhancement, and cine
steady-state free precession (SSFP) sequences, we were able to clearly demonstrate endocardial fibrosis, tissue
inflammation, apical ventricular hypertrophy, and LV thrombus that correlate with clinical findings. We believe cardiac
MRI is more useful than transthoracic echocardiography in the diagnosis and management of HES and ultimately it
obviated the need for biopsy to confirm the diagnosis.
 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Epidemiologic data of endomyocardial fibrosis(EMF) continues to be scarce, despite the fact
that EMF is considered the most common form of
restrictive cardiomyopathy [1]. Most studies of
EMF occur in tropical regions such as Uganda
where there is a high prevalence of the disease.
Loeffler’s endocarditis was first described as a
component of a multi-system disease in 1968,
when Hardy and Anderson published a paper
titled The hypereosinophilic syndromes [2] (HES).Thereafter, Parrillo et al. [3] studied 26 patients
with hypereosinophilic syndrome. The data pro-
vided a correlation between hypereosinophilic
syndrome and Loeffler’s endocarditis. It also
showed that about 40–50% of patients with hype-
reosinophilic syndrome have cardiac involvement.
Previous studies reveal that about 10% of
patients with rheumatoid arthritis (RA) have
hypereosinophilia (HE). They show that HE might
occur either due to a reaction from the RA drug
therapy or in relation to the RA process as a result
of extra-articular vasculitis [4].NC-ND
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ticoids and myelo-suppressive drugs. The latter is
used in cases that are resistant to glucocorticoids
and in severe forms of HES. Glucocorticoids inhi-
bit many chemical mediators and are known to be
the most effective therapy. In addition to the
above mentioned treatment, treatment of the
cause will be added in cases of secondary HES
[5,6].
In this case report, we describe a patient with
rheumatoid arthritis under treatment, and suffer-
ing from eosinophilia. We also describe the typical
cardiac magnetic resonance (CMR) findings of
Loeffler’s endocarditis.
History: We report the case of a 36-year-old
female patient known to have rheumatoid
arthritis and referred for CMR to investigate
disabling dyspnea:
Lab findings
Rheumatoid factor (latex = positive 1/
16 = 192 IU/ml).
CRP: positive (8 mg/L).
Anti CCP: positive = 990 u/ml.
Microcytic hypochromic anemia (hemoglo-
bin = 8.3 g/dl, MCV = 69.5 fl).
Mild thrombocytopenia (121  103/cmm).
Eosinophil count = 12%, increased to 28% with
three-month interval between both blood
counts.
Clinical chemical analysis including liver
enzymes, bilirubin and renal functions were
within the normal ranges.
Stool analysis: Negative for parasitic
infestation.
Immunology report
Anti-PR3 hs = 1.4 U/ml (normal).
Anti-MPO IgG (p-ANCA) = 1.5 U/ml (normal).
Anti-B2-glycoprotein 1 IgM = 2.4 MPL U/ml
(normal).
Anti-cardiolipin IgGAM screen = 4.7 U/ml
(normal).
Anti-nuclear abs = negative.
Anti ds DNA = 18 U/ml (normal).
Protein C = 60%.
Protein S = 35%.
Doppler lower limbs
Moderate to sever lower limb ischemia.
Aortoiliac occlusion with ankle/brachial
index = 0.4.
Echo findings
Obliteration of the left ventricle (LV) apex with
possible LV apical thrombus.
Good ventricular systolic functions.
Mitral valve: Mildly thickened leaflets with restricted pos-
terior leaflet and diastolic doming of the
anterior leaflet.
 Leaflet excursion is adequate.
 Eccentric mitral regurge.
 Regurgitate jet is directed extremely poster-
ior swirling over the left atrial wall 5.5 cm2,
PISA radius: 0.8 cm.
Dilated left atrium:
CT chest: Widespread mosaic appearance in
both lung fields.
U/S Abdomen: Fatty liver.
Materials and methods
CMR: The study was performed using a 1.5 T
Magnet (Philips-MRI, Achieva).
CMR sequences and protocols were performed
as previously described [7,8].
A. Sequences
1. Cine steady state free precession (SSFP): in
short axis, 2-chamber, 4-chamber and axial
views in order to assess cardiac volumes
and functions. Slice thickness was 8 mm.
Acquisition was during breath hold com-
mands. TE:1.7 ms and TR:3.3 ms. Stacks of
slices in the axial and short axis views cov-
ered both ventricles from the atrioventricu-
lar (AV) junction to the apex.
2. Dark blood sequences: T1 Turbo spin echo
(TSE) and T2 TSE were acquired for tissue
characterization before and after contrast
injection in breath hold mode.
3. Inversion recovery (IR) images: These were
acquired using the phase sensitive inver-
sion recovery (PSIR) and FLASH
sequences. Acquisition was 10 min after
intravenous injection of MRI gadolinium
(Magnevist) contrast material to detect the
pattern of the late gadolinium enhance-
ment (LGE). Slice thickness was 10 mm.
Views were acquired mid-ventricular in
short axis, 2-chamber and 4-chamber
views.
4. Velocity encoding phase contrast (VENC):
Blood flow was measured as previously
described. In brief, a double oblique through
plane in the vessel of interest was carefully
planned. The physician responsible for the
visit carefully screened the ECG along the
entire sequence. Usually, if more than three
untriggered pulses occurred, the sequence
was aborted and repeated, [9] as the
policy of our center is to have no flow
Figure 1. Inversion recovery images 10 min after contrast injection showing left ventricular apical thrombus (red circles) and sub-endocardial
enhancement (blue arrows).
Figure 2. SSFP axial view showing apical bi-ventricular hypertrophy
with obliteration of the RV apex.
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measurements. Slice thickness 8 mm, VENC:
200 cm/s in 30 cardiac phases. Measurements
were performed in the aorta, pulmonary
artery, and mitral valve.
5. Indirect method of calculating the mitral reg-
urge (MI) was aorta stroke volume – stroke
volume of LV.
B. Contrast material: MRI gadolinium (Magne-
vist) contrast material. Dose injected was
0.14 mmol/kg. Renal functions were checked
before injecting the contrast material.
C. Data assessment: The images were viewed
and post-processed by the author. In order
to calculate the cardiac volumes and
functions, the end diastolic and end systolic
volumes were identified visually as the
cardiac phase showing the largest and
smallest ventricular volumes respectively.
Endomyocardial contouring was traced semi
automatically. The papillary muscles were
excluded from the ventricular volumes.
Results
The acquisition extended for 60 min. Amount of
injected contrast was about 16 ml. The ventricular
volumes and functions were calculated using the
available workstation in the Philips MRI. Ventric-
ular volumes and functions were normalized to
body surface area.
The CMR showed the following findings:
 Diffuse subendocardial late gadolinium
enhancement involving both the left ventricle(LV) and the right ventricle (RV) (blue arrows)
(Fig. 1).
 An apical RV and LV wall thickening with
almost total obliteration of the RV apex (Fig. 2).
 LV apical dark signal thrombus showing no
evidence of contrast material in the LGE (red
circles) (Fig. 1).
 Preserved bi-ventricular systolic functions.
 Normal bi-ventricular volumes.
 Mild MI: 12–13% (Fig. 3). Mild Pericardial
effusion (Fig. 4).
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Figure 3. SSFP two-chamber view showing dark jet artifact during left ventricle systole across the mitral valve into the left atrium denoting
mitral valve insufficiency.
Figure 4. SSFP two-chamber view showing pericardial effusion.
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CMR is a key tool for diagnosing and monitor-
ing, and for the prognostic stratification of most
cardiomyopathies. It provides a full assessment
of systolic and diastolic functions, and tissue
characterization, particularly of fibrosis, using
delayed-enhancement sequences (DE) [3,10].
Endomyocardial fibrosis is characterized by the
deposition of fibrous tissue in the endocardium,predominantly in the apices of the right and left
ventricles, and considered to belong to the group
of restrictive cardiomyopathies [11,12].
Endomyocardial fibrosis lesions in Loeffler’s
endocarditis are probably secondary to hypereo-
sinophilic syndromes. This is due to the role
played by the increased eosinophil count and
serotonin secretion in the pathological process,
causing damage and necrosis of the endocardium
[13,14]. Blood picture in our case was performed
twice with a six-month interval showing a rise in
the eosinophil percentage.
In practice, transthoracic echocardiography is
the first examination to be performed and
provides an accurate evaluation of systolic and
diastolic functions. The advantages of echocardi-
ography is its non-invasiveness and relatively
low-cost. In our case, it showed an apical
thrombus and evaluation of the systolic cardiac
functions. However, the limitations of echocardi-
ography can be summarized in its tissue charac-
terization and differential diagnosis of restrictive
cardiomyopathies [15].
CMR plays an important role in the diagnosis
and prognosis of this condition. It provides precise
morphological evaluation, usually characterized
by restriction with non-dilated or small ventricles,
with an element of hypertrophy, more in the
apical regions. In the current case, ventricles were
not dilated but apices of both ventricles were
hypertrophied with obliteration of the RV apex.
Among typical CMRfindings, described in litera-
ture [13] and which are present in the current case
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severe diastolic dysfunction with a restrictive
disorder. IR sequences after contrast injection con-
firm diagnosis by showing typical subendocardial
enhancement extending from the subvalvular
regions to the apices of the two ventricles. Thrombi
are frequently described at the apex of the LV and/
or RV.
The disadvantages of cardiac MRI are its costs,
which are higher than echocardiography. How-
ever, the emergence of new techniques and soft-
ware have allowed rapid acquisitions, and in
turn, a shorter scan time as well as decreased
use of contrast material in some scenarios. More-
over, in today’s case the cost benefit is considered
relatively high, since cardiac MRI saved the costs
of a performing biopsy.
In our current case, medical treatment included
diuretics and anti-rheumatic medication, which
were used to improve dyspnea. Initially, the
patient received low molecular weight heparin
(Clexane) treatment. It was withdrawn under
cover of the warfarin anticoagulant (Marevan).
The patient was advised to continue on Marevan
treatment and dismissed from the hospital. A fol-
low-up MRI was recommended after one year to
assess the patient’s cardiac functions and the
delayed enhancement, and hence the efficacy of
the treatment.
The utility of endomyocardial biopsy is cur-
rently being reviewed in consideration of new
advances in diagnostics [16]. A myocardial biopsy
in our case was avoided after the provision of a
competent CMR diagnosis, which highly corre-
lated with clinical findings.Conclusion
CMR yielded significant diagnostic information,
which was not found with a transthoracic echocar-
diography. CMR is non-invasive, and can compe-
tently assist in the diagnosis of endomyocardial
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